Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.
Identifieur interne : 007918 ( PubMed/Checkpoint ); précédent : 007917; suivant : 007919Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.
Auteurs : Susanna Curtis [États-Unis] ; Simon Hong ; Rasim Gucalp ; Manuela CalvoSource :
- American journal of therapeutics [ 1536-3686 ]
Descripteurs français
- KwdFr :
- MESH :
- analogues et dérivés : Désoxycytidine.
- effets indésirables : Antinéoplasiques antimétabolites, Désoxycytidine.
- Adulte, Cellulite sous-cutanée, Humains, Lymphoedème, Mâle, Récidive.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antimetabolites, Antineoplastic, Deoxycytidine.
- chemical , analogs & derivatives : Deoxycytidine.
- chemically induced : Cellulitis.
- complications : Lymphedema.
- Adult, Humans, Male, Recurrence.
Abstract
Gemcitabine is a chemotherapeutic agent used for treatment of a variety of malignancies. It has been associated with multiple cutaneous reactions including rash, alopecia, and pruritus. Less commonly, gemcitabine has been associated with "pseudocellulitis," a noninfectious skin inflammatory reaction, which resembles cellulitis. The majority of cases reported in the literature are radiation recall reactions in which inflammation occurs in areas of previous radiation post drug treatment; however, there are also reports of pseudocellulitis occurring in areas of preexisting lymphedema. The pathophysiology of both of these reactions are still unknown, though it is theorized that areas of lymphedema may both increase concentration of gemcitabine and reduce its rate of metabolism leading to increased drug exposure time. In this study, we report a case of pseudocellulitis in a patient with chronic lower extremity lymphedema and a review of the current literature. By recognizing this side effect of gemcitabine, one can avoid unnecessary hospitalization and exposure to antibiotics.
DOI: 10.1097/MJT.0000000000000024
PubMed: 24451298
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:24451298Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.</title><author><name sortKey="Curtis, Susanna" sort="Curtis, Susanna" uniqKey="Curtis S" first="Susanna" last="Curtis">Susanna Curtis</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Montefiore Medical Center, Bronx, NY.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Medicine, Montefiore Medical Center, Bronx</wicri:cityArea></affiliation></author><author><name sortKey="Hong, Simon" sort="Hong, Simon" uniqKey="Hong S" first="Simon" last="Hong">Simon Hong</name></author><author><name sortKey="Gucalp, Rasim" sort="Gucalp, Rasim" uniqKey="Gucalp R" first="Rasim" last="Gucalp">Rasim Gucalp</name></author><author><name sortKey="Calvo, Manuela" sort="Calvo, Manuela" uniqKey="Calvo M" first="Manuela" last="Calvo">Manuela Calvo</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2016 Jan-Feb</MedlineDate></PubDate></date><idno type="RBID">pubmed:24451298</idno><idno type="pmid">24451298</idno><idno type="doi">10.1097/MJT.0000000000000024</idno><idno type="wicri:Area/PubMed/Corpus">001715</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001715</idno><idno type="wicri:Area/PubMed/Curation">001715</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001715</idno><idno type="wicri:Area/PubMed/Checkpoint">001715</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001715</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.</title><author><name sortKey="Curtis, Susanna" sort="Curtis, Susanna" uniqKey="Curtis S" first="Susanna" last="Curtis">Susanna Curtis</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Montefiore Medical Center, Bronx, NY.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Medicine, Montefiore Medical Center, Bronx</wicri:cityArea></affiliation></author><author><name sortKey="Hong, Simon" sort="Hong, Simon" uniqKey="Hong S" first="Simon" last="Hong">Simon Hong</name></author><author><name sortKey="Gucalp, Rasim" sort="Gucalp, Rasim" uniqKey="Gucalp R" first="Rasim" last="Gucalp">Rasim Gucalp</name></author><author><name sortKey="Calvo, Manuela" sort="Calvo, Manuela" uniqKey="Calvo M" first="Manuela" last="Calvo">Manuela Calvo</name></author></analytic><series><title level="j">American journal of therapeutics</title><idno type="eISSN">1536-3686</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antimetabolites, Antineoplastic (adverse effects)</term><term>Cellulitis (chemically induced)</term><term>Deoxycytidine (adverse effects)</term><term>Deoxycytidine (analogs & derivatives)</term><term>Humans</term><term>Lymphedema (complications)</term><term>Male</term><term>Recurrence</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Antinéoplasiques antimétabolites (effets indésirables)</term><term>Cellulite sous-cutanée ()</term><term>Désoxycytidine (analogues et dérivés)</term><term>Désoxycytidine (effets indésirables)</term><term>Humains</term><term>Lymphoedème ()</term><term>Mâle</term><term>Récidive</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antimetabolites, Antineoplastic</term><term>Deoxycytidine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Deoxycytidine</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Désoxycytidine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Cellulitis</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques antimétabolites</term><term>Désoxycytidine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Humans</term><term>Male</term><term>Recurrence</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Cellulite sous-cutanée</term><term>Humains</term><term>Lymphoedème</term><term>Mâle</term><term>Récidive</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Gemcitabine is a chemotherapeutic agent used for treatment of a variety of malignancies. It has been associated with multiple cutaneous reactions including rash, alopecia, and pruritus. Less commonly, gemcitabine has been associated with "pseudocellulitis," a noninfectious skin inflammatory reaction, which resembles cellulitis. The majority of cases reported in the literature are radiation recall reactions in which inflammation occurs in areas of previous radiation post drug treatment; however, there are also reports of pseudocellulitis occurring in areas of preexisting lymphedema. The pathophysiology of both of these reactions are still unknown, though it is theorized that areas of lymphedema may both increase concentration of gemcitabine and reduce its rate of metabolism leading to increased drug exposure time. In this study, we report a case of pseudocellulitis in a patient with chronic lower extremity lymphedema and a review of the current literature. By recognizing this side effect of gemcitabine, one can avoid unnecessary hospitalization and exposure to antibiotics.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24451298</PMID><DateCreated><Year>2016</Year><Month>01</Month><Day>08</Day></DateCreated><DateCompleted><Year>2016</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-3686</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><MedlineDate>2016 Jan-Feb</MedlineDate></PubDate></JournalIssue><Title>American journal of therapeutics</Title><ISOAbbreviation>Am J Ther</ISOAbbreviation></Journal><ArticleTitle>Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.</ArticleTitle><Pagination><MedlinePgn>e321-3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MJT.0000000000000024</ELocationID><Abstract><AbstractText>Gemcitabine is a chemotherapeutic agent used for treatment of a variety of malignancies. It has been associated with multiple cutaneous reactions including rash, alopecia, and pruritus. Less commonly, gemcitabine has been associated with "pseudocellulitis," a noninfectious skin inflammatory reaction, which resembles cellulitis. The majority of cases reported in the literature are radiation recall reactions in which inflammation occurs in areas of previous radiation post drug treatment; however, there are also reports of pseudocellulitis occurring in areas of preexisting lymphedema. The pathophysiology of both of these reactions are still unknown, though it is theorized that areas of lymphedema may both increase concentration of gemcitabine and reduce its rate of metabolism leading to increased drug exposure time. In this study, we report a case of pseudocellulitis in a patient with chronic lower extremity lymphedema and a review of the current literature. By recognizing this side effect of gemcitabine, one can avoid unnecessary hospitalization and exposure to antibiotics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Curtis</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Montefiore Medical Center, Bronx, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Gucalp</LastName><ForeName>Rasim</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Manuela</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Ther</MedlineTA><NlmUniqueID>9441347</NlmUniqueID><ISSNLinking>1075-2765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000964">Antimetabolites, Antineoplastic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0W860991D6</RegistryNumber><NameOfSubstance UI="D003841">Deoxycytidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>B76N6SBZ8R</RegistryNumber><NameOfSubstance UI="C056507">gemcitabine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000964" MajorTopicYN="N">Antimetabolites, Antineoplastic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002481" MajorTopicYN="N">Cellulitis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003841" MajorTopicYN="N">Deoxycytidine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24451298</ArticleId><ArticleId IdType="doi">10.1097/MJT.0000000000000024</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><noCountry><name sortKey="Calvo, Manuela" sort="Calvo, Manuela" uniqKey="Calvo M" first="Manuela" last="Calvo">Manuela Calvo</name><name sortKey="Gucalp, Rasim" sort="Gucalp, Rasim" uniqKey="Gucalp R" first="Rasim" last="Gucalp">Rasim Gucalp</name><name sortKey="Hong, Simon" sort="Hong, Simon" uniqKey="Hong S" first="Simon" last="Hong">Simon Hong</name></noCountry><country name="États-Unis"><region name="État de New York"><name sortKey="Curtis, Susanna" sort="Curtis, Susanna" uniqKey="Curtis S" first="Susanna" last="Curtis">Susanna Curtis</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007918 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 007918 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:24451298
|texte= Gemcitabine-Induced Pseudocellulitis in a Patient With Recurrent Lymphedema: A Case Report and Review of the Current Literature.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:24451298" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |